ALBANY, New York, April 22, 2014 /PRNewswire/ -- AMRI (NASDAQ:
AMRI) today announced it will issue first quarter financial results
before the opening of the market on Tuesday,
May 6, 2014. Following the release of its results, the
company will host a conference call and simultaneous audio webcast
at 10:00 a.m. ET.
The conference call can be accessed by dialing 888-438-5524
(domestic calls) or +1-719-325-2448 (international calls) at
9:50 a.m. ET and entering passcode
8361277. The audio webcast will be available live via the Internet
and can be accessed on the company's website at www.amriglobal.com.
Replays of the audio webcast can also be accessed for up to 90 days
after the call via the investor area of the company's website at
www.amriglobal.com/investor_relations/.
About AMRI
Albany Molecular Research, Inc. (AMRI) is a global contract
research and manufacturing organization offering customers fully
integrated drug discovery, development, and manufacturing services.
For over 22 years AMRI has demonstrated its adaptability as the
pharmaceutical and biotechnology industries have undergone
tremendous change in response to multiple challenges. This
experience, a track record of success and locations in the United States, Europe and Asia now provides our customers with
SMARTSOURCING™, a full range of value-added opportunities providing
customers informed decision-making, enhanced efficiency and more
successful outcomes at all stages of the pipeline. AMRI has also
successfully partnered R&D programs and is actively seeking to
out-license its remaining programs for further development. For
more information about AMRI, please visit our website at
www.amriglobal.com or follow us on Twitter (@amriglobal).